Zobrazeno 1 - 3
of 3
pro vyhledávání: '"van Mil LWHG"'
Autor:
van Hooren L; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Handgraaf SM; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kloosterman DJ; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Karimi E; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., van Mil LWHG; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Gassama AA; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Solsona BG; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Groot MHP; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Quail DF; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Physiology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Walsh LA; Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., Borst GR; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health and Manchester Cancer Research Centre, University of Manchester, Manchester, UK. gerben.borst@nhs.net.; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK. gerben.borst@nhs.net., Akkari L; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. l.akkari@nki.nl.
Publikováno v:
Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 665-681. Date of Electronic Publication: 2023 Apr 20.
Autor:
Martens AWJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands., Rietveld JM; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., de Boer R; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Peters FS; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands., Ngo A; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Mil LWHG; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., de Heer K; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Hematology, Flevoziekenhuis, Almere, the Netherlands., Spaargaren M; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Pathology, University of Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands., Verkleij CPM; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van de Donk NWCJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Adams HC 3rd; Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania., Eldering E; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands., van Noesel CJM; Department of Pathology, University of Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands., Verona R; Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam Infection & Immunity Institute, Amsterdam, the Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, the Netherlands.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 May 09; Vol. 2 (5), pp. 330-341. Date of Electronic Publication: 2022 May 09 (Print Publication: 2022).
Autor:
Akbari P; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Katsarou A; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Daghighian R; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., van Mil LWHG; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Huijbers EJM; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Griffioen AW; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: a.griffioen@amsterdamumc.nl., van Beijnum JR; Amsterdam UMC, Vrije Universiteit Amsterdam, Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: j.vanbeijnum01@gmail.com.
Publikováno v:
Biochimica et biophysica acta. Reviews on cancer [Biochim Biophys Acta Rev Cancer] 2022 May; Vol. 1877 (3), pp. 188701. Date of Electronic Publication: 2022 Feb 22.